Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66985-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- FBL antibody
- Antibody type
- Monoclonal
- Description
- FBL antibody (Cat. #66985-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, rat, mouse and has been validated for the following applications: FC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 3A9E8
- Vial size
- 20ul, 150ul
Submitted references TRIM21-Mediated ubiquitination of FBL suppresses PI3K/AKT signaling and tumor progression in clear cell renal cell carcinoma.
Protocol for investigating phase transition of prion-like proteins in vitro with concentration variation.
NAP-seq reveals multiple classes of structured noncoding RNAs with regulatory functions.
Protein expression of nucleolar protein 12 in the retina and its implication in protection of retina from UV irradiation damage.
Eukaryotic translation initiation factor 6-mediated ribosome biogenesis promotes synovial aggression and inflammation by increasing the translation of SP1 in rheumatoid arthritis.
lncRNAs maintain the functional phase state of nucleolar prion-like protein to facilitate rRNA processing.
Nucleolar HEAT Repeat Containing 1 Up-regulated by the Mechanistic Target of Rapamycin Complex 1 Signaling Promotes Hepatocellular Carcinoma Growth by Dominating Ribosome Biogenesis and Proteome Homeostasis.
A pair of long intergenic non-coding RNA LINC00887 variants act antagonistically to control Carbonic Anhydrase IX transcription upon hypoxia in tongue squamous carcinoma progression.
LncRNA FAM83A-AS1 promotes lung adenocarcinoma progression by enhancing the pre-mRNA stability of FAM83A.
Guan B, Tang H, Yuan Z, Yao J, Cui D, Hao Z, Li X
Cellular and molecular life sciences : CMLS 2026 Mar 21;83(1)
Cellular and molecular life sciences : CMLS 2026 Mar 21;83(1)
Protocol for investigating phase transition of prion-like proteins in vitro with concentration variation.
Chen XT, Sun YM, Wang WT, Chen YQ, Chen TQ
STAR protocols 2025 Sep 19;6(3):103910
STAR protocols 2025 Sep 19;6(3):103910
NAP-seq reveals multiple classes of structured noncoding RNAs with regulatory functions.
Liu S, Huang J, Zhou J, Chen S, Zheng W, Liu C, Lin Q, Zhang P, Wu D, He S, Ye J, Liu S, Zhou K, Li B, Qu L, Yang J
Nature communications 2024 Mar 18;15(1):2425
Nature communications 2024 Mar 18;15(1):2425
Protein expression of nucleolar protein 12 in the retina and its implication in protection of retina from UV irradiation damage.
Liu J, Tan X, Li L, Cao L, Zhou Y, Li H, Peng T
Cell death discovery 2024 Mar 11;10(1):130
Cell death discovery 2024 Mar 11;10(1):130
Eukaryotic translation initiation factor 6-mediated ribosome biogenesis promotes synovial aggression and inflammation by increasing the translation of SP1 in rheumatoid arthritis.
Shen C, Peng C, Zhang S, Li R, Liu S, Kuang Y, Su F, Liu Y, Liang L, Xiao Y, Xu H
International immunopharmacology 2024 Dec 5;142(Pt B):113164
International immunopharmacology 2024 Dec 5;142(Pt B):113164
lncRNAs maintain the functional phase state of nucleolar prion-like protein to facilitate rRNA processing.
Sun YM, Zhu SX, Chen XT, Pan Q, An Y, Chen TQ, Huang HJ, Pu KJ, Lian JY, Zhao WL, Wang WT, Chen YQ
Molecular cell 2024 Dec 19;84(24):4878-4895.e10
Molecular cell 2024 Dec 19;84(24):4878-4895.e10
Nucleolar HEAT Repeat Containing 1 Up-regulated by the Mechanistic Target of Rapamycin Complex 1 Signaling Promotes Hepatocellular Carcinoma Growth by Dominating Ribosome Biogenesis and Proteome Homeostasis.
Yang XM, Wang XQ, Hu LP, Feng MX, Zhou YQ, Li DX, Li J, Miao XC, Zhang YL, Yao LL, Nie HZ, Huang S, Xia Q, Zhang XL, Jiang SH, Zhang ZG
Gastroenterology 2023 Sep;165(3):629-646
Gastroenterology 2023 Sep;165(3):629-646
A pair of long intergenic non-coding RNA LINC00887 variants act antagonistically to control Carbonic Anhydrase IX transcription upon hypoxia in tongue squamous carcinoma progression.
Shen T, Xia W, Min S, Yang Z, Cheng L, Wang W, Zhan Q, Shao F, Zhang X, Wang Z, Zhang Y, Shen G, Zhang H, Wu LL, Yu GY, Kong QP, Wang X
BMC biology 2021 Sep 7;19(1):192
BMC biology 2021 Sep 7;19(1):192
LncRNA FAM83A-AS1 promotes lung adenocarcinoma progression by enhancing the pre-mRNA stability of FAM83A.
Wang W, Zhao Z, Xu C, Li C, Ding C, Chen J, Chen T, Zhao J
Thoracic cancer 2021 May;12(10):1495-1502
Thoracic cancer 2021 May;12(10):1495-1502
No comments: Submit comment
No validations: Submit validation data